首页> 外文期刊>Journal of Enam Medical College >Acute Renal Failure as Part of Multi-Organ Failure: How Long We Should Wait before We Intervene? A Dissection of Studies
【24h】

Acute Renal Failure as Part of Multi-Organ Failure: How Long We Should Wait before We Intervene? A Dissection of Studies

机译:急性肾脏衰竭是多器官衰竭的一部分:干预之前我们应该等待多长时间?研究剖析

获取原文
       

摘要

Mortality rate in multisystem organ failure (MOF) is very high. Acute renal failure is an important part of MOF. In this special feature article I have aimed to streamline the achievements of different studies on continuous renal replacement therapy (CRRT) for a fruitful outcome. For this I have gone for retrospective evaluation of the studies reached through PubMed, internet alert system of different journals, proceedings of conferences on CRRT and personal communication with the experts in this field. I have evaluated the outcome of studies to explore the causes of failure to achieve a positive result and to identify the positive gains of studies. Finally, I have compiled the positive gains to outline a new strategy for future study and greater achievement. The findings of evaluation led to the conclusion that while planning for initiation of CRRT, multiple strategies should be targeted. The strategy should involve early initiation of CRRT guided by new markers of acute kidney injury (AKI), continuous venovenous hemofiltration (CVVH) modality, optimum intensity (intensity should be adequate enough to improve hemodynamics within a targeted period), selection of an effective filter membrane. Elderly patients should be studied in a different group. Cardiac patients with AKI should not be studied in the same group along with the patients with sepsis DOI: http://dx.doi.org/10.3329/jemc.v5i1.21496 J Enam Med Col 2015; 5(1): 39-43
机译:多系统器官衰竭(MOF)的死亡率很高。急性肾衰竭是MOF的重要组成部分。在这篇专题文章中,我旨在精简连续肾脏替代疗法(CRRT)的各种研究成果,以取得丰硕的成果。为此,我对通过PubMed,不同期刊的互联网警报系统,CRRT会议记录以及与该领域专家进行的个人交流所进行的研究进行了回顾性评估。我评估了研究的结果,以探究未能取得积极结果的原因并确定研究的积极成果。最后,我整理了一些积极成果,以概述一种新的策略,以供将来学习和取得更大成就。评估结果得出的结论是,在计划启动CRRT的同时,应针对多种策略。该策略应包括在急性肾损伤(AKI)的新标记,持续静脉静脉血液滤过(CVVH)方式,最佳强度(强度应足以在目标时间内改善血液动力学)的指导下尽早开始CRRT。膜。老年患者应在不同的组中进行研究。不应将患有AKI的心脏病患者与败血症DOI一起在同一组中研究:http://dx.doi.org/10.3329/jemc.v5i1.21496 J Enam Med Col 2015; 5(1):39-43

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号